Bids For Merck & Co., Inc.'s Consumer Business Could Fetch $10 Billion

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Merck & Co.'s effort to sell its portfolio of well-known consumer brands including Coppertone sun screen and Claritin allergy pills is kicking into high gear, with consumer and health care giants expected to put in bids that could top $10 billion, according to people familiar with the matter. Merck, which has said publicly it is exploring options for the business, has already received preliminary offers for it, the people said. Merck officials will begin meeting with possible buyers next week, and final bids will likely be due late next month, one of the people said.

Help employers find you! Check out all the jobs and post your resume.

Back to news